Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07110441 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
A Phase 1 study, sponsored by Genfit.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT07110441 is a Phase 1 study that has completed, run by Genfit. The registered enrollment target is 52 participants.
The verdict
NCT07110441, a Phase 1 study, has completed, sponsored by Genfit.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects
Interventions
- DRUG Single Dose G1090N
- DRUG Multiple dosing of G1090N
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2025-08-26 |
| Est. Completion | 2025-12-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07110441
The ClinicalTrials.gov registry entry for NCT07110441 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genfit, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Single Dose G1090N is the first listed.
NCT07110441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07110441 about?
NCT07110441 is a clinical study titled "Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers". A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects
What is the current status of trial NCT07110441?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2025-08-26. Estimated completion is 2025-12-03.
What interventions are being tested in trial NCT07110441?
The interventions under investigation include: Single Dose G1090N (DRUG), Multiple dosing of G1090N (DRUG).
Who is sponsoring clinical trial NCT07110441?
This trial is sponsored by Genfit, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.